View in EDS HTML Full Text PDF Full Text

The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis.

Saved in:
Bibliographic Details
Title: The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis.
Authors: Chai SJ; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Yu T; The Second Hospital of Jilin University, Changchun, Hebei, China., Wang GR; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Sun FL; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Xue H; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Zhang Z; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Ran B; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Jun 19; Vol. 16, pp. 1579101. Date of Electronic Publication: 2025 Jun 19 (Print Publication: 2025).
Publication Type: Journal Article; Systematic Review; Network Meta-Analysis
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40612431
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chai+SJ%22">Chai SJ</searchLink>; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.<br /><searchLink fieldCode="AU" term="%22Yu+T%22">Yu T</searchLink>; The Second Hospital of Jilin University, Changchun, Hebei, China.<br /><searchLink fieldCode="AU" term="%22Wang+GR%22">Wang GR</searchLink>; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.<br /><searchLink fieldCode="AU" term="%22Sun+FL%22">Sun FL</searchLink>; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.<br /><searchLink fieldCode="AU" term="%22Xue+H%22">Xue H</searchLink>; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.<br /><searchLink fieldCode="AU" term="%22Ran+B%22">Ran B</searchLink>; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101555782%22">Frontiers in endocrinology</searchLink> [Front Endocrinol (Lausanne)] 2025 Jun 19; Vol. 16, pp. 1579101. <i>Date of Electronic Publication: </i>2025 Jun 19 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review; Network Meta-Analysis
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101555782 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2392 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642392%22">16642392 </searchLink><i>NLM ISO Abbreviation: </i>Front Endocrinol (Lausanne) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40612431
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fendo.2025.1579101
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1579101
    Titles:
      – TitleFull: The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chai SJ
      – PersonEntity:
          Name:
            NameFull: Yu T
      – PersonEntity:
          Name:
            NameFull: Wang GR
      – PersonEntity:
          Name:
            NameFull: Sun FL
      – PersonEntity:
          Name:
            NameFull: Xue H
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: Ran B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 06
              Text: 2025 Jun 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1664-2392
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in endocrinology
              Type: main
ResultId 1